Evolution of dry powder inhaler design, formulation, and performance.
Explore this paper's citation graph
Summary
A well-designed DPI and an appropriate powder formulation can optimize the effectiveness of inhaled drug therapy and recent advances in formulation technology can increase lung dose and reduce its variability.
- Type
- review
- Published
- 2002-05-01
- Cited by
- 335
- References
- 62
- Access
- Open access
- OpenAlex
- https://openalex.org/W1991564189
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:43650299
Keywords
Dry-powder inhaler, Medicine, Inhaler, Consistency (knowledge bases), Drug
References
- Novel Lipid-Based Hollow-Porous Microparticles as a Platform for Immunoglobulin Delivery to the Respiratory Tract
- Turbuhaler: A New Powder Inhaler for Administration of Drugs to the Airways
- Respiratory Drug Delivery
- Aerosol Electrostatics I: Properties of Fine Powders Before and After Aerosolization by Dry Powder Inhalers
- A Method for Determination of the Absolute Pulmonary Bioavailability of Inhaled Drugs: Terbutaline
- The importance of particle size in response to inhaled bronchodilators.
- The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler).
- Effect of powder inhaler design on drug deposition in the respiratory tract
- Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI.
- A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler, at two inhaled flow rates
- Large porous particles for pulmonary drug delivery.
- Medical Aerosol Inhalers: Past, Present, and Future
- Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device.
- Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
- On the relationship between drug and carrier deposition from dry powder inhalers in vitro
- Deposition, retention, and clearance of inhaled particles.
- Is total particle dose more important than particle distribution?
- Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
- Scintigraphic Assessment of Drug Delivery from the Ultrahaler Dry Powder Inhaler
- Latest advances in the development of dry powder inhalers.
Cited by
- A subcellular compartmental modeling approach to pulmonary drug development
- A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins.
- Functionalization of lactose as a biological carrier for bovine serum albumin by electrospraying.
- Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
- Respirable microparticles of aminoglycoside antibiotics for pulmonary administration
- Engineering of particles for inhalation
- The Development of A New Dry Powder Inhaler
- Novel methodology to characterise how asthma and chronic obstructive pulmonary disease patients use their inhalers and methods to improve their inhaler technique Objective assessment of how patients use inhalers
- Novolizer® multidose dry powder inhaler
- Cationic, amphiphilic dextran nanomicellar clusters as an excipient for dry powder inhaler formulation.
- Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery
- CFD Assessment of Respiratory Drug Delivery Efficiency in Adults and Improvements Using Controlled Condensational Growth
- Investigation and optimization of a solvent/anti-solvent crystallization process for the production of inhalation particles
- DEM-CFD analysis of micromechanics for dry powder inhalers
- Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
- Experimental and computational study of multiphase flow in dry powder inhalers
- Use of dry powder inhalers in COPD
- The micro and nano scale characterization and identification of tablet formulations
- Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler
- Use of inhaler devices and asthma control in severe asthma patients at a referral center in the city of Salvador, Brazil.
Related papers
- Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique.
- The Genuair® inhaler: a novel, multidose dry powder inhaler
- Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods?
- Monitoring of Inhalation Using a Pressurized Metered-dose Inhaler (pMDI) Fitted with a Differential Pressure Sensor and Its Applications in Inhaler Technique Training
- An easy-to-use dry-powder inhaler
- COMPARISON OF SINGLE-DOSE EFFICACY OF ALBUTEROL-HYDROFLUOROALKANE BREATH-ACTUATED INHALER AND ALBUTEROL-HYDROFLUOROALKANE METERED-DOSE INHALER IN ASTHMA PATIENTS WITH POOR INHALER COORDINATING ABILITY
- Comparison of conventional metered dose inhaler and breath actuated inhaler in elderly patients
- Use of a new dry powder inhaler to deliver umeclidinium/vilanterol in the treatment of COPD
- Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma.